Ending the HIV epidemic in the USA: an economic modelling study in six cities B Nosyk, X Zang, E Krebs, B Enns, JE Min, CN Behrends, C Del Rio, ... The Lancet HIV 7 (7), e491-e503, 2020 | 56 | 2020 |
Cost-effectiveness of publicly funded treatment of opioid use disorder in California E Krebs, B Enns, E Evans, D Urada, MD Anglin, RA Rawson, YI Hser, ... Annals of internal medicine 168 (1), 10-19, 2018 | 51 | 2018 |
The impact of localized implementation: determining the cost-effectiveness of HIV prevention and care interventions across six United States cities E Krebs, X Zang, B Enns, JE Min, CN Behrends, C Del Rio, ... Aids 34 (3), 447-458, 2020 | 47 | 2020 |
Building the case for localized approaches to HIV: structural conditions and health system capacity to address the HIV/AIDS epidemic in six US cities D Panagiotoglou, M Olding, B Enns, DJ Feaster, C Del Rio, LR Metsch, ... AIDS and Behavior 22, 3071-3082, 2018 | 42 | 2018 |
Developing a dynamic HIV transmission model for 6 US cities: an evidence synthesis E Krebs, B Enns, L Wang, X Zang, D Panagiotoglou, C Del Rio, ... PloS one 14 (5), e0217559, 2019 | 41 | 2019 |
“Ending the epidemic” will not happen without addressing racial/ethnic disparities in the United States human immunodeficiency virus epidemic B Nosyk, E Krebs, X Zang, M Piske, B Enns, JE Min, CN Behrends, ... Clinical Infectious Diseases 71 (11), 2968-2971, 2020 | 35 | 2020 |
A historical review of HIV prevention and care initiatives in British Columbia, Canada: 1996‐2015 M Olding, B Enns, D Panagiotoglou, J Shoveller, PR Harrigan, R Barrios, ... African Journal of Reproduction and Gynaecological Endoscopy 20 (1), 2017 | 34 | 2017 |
The costs of crime associated with stimulant use in a Canadian setting B Enns, E Krebs, K DeBeck, K Hayashi, MJ Milloy, L Richardson, E Wood, ... Drug and alcohol dependence, 2017 | 22 | 2017 |
Virtual overdose monitoring services/mobile overdose response services: estimated number of potentially averted drug poisoning fatality events by various telephone and digital … W Rioux, B Enns, SM Ghosh Frontiers in public health 11, 1242795, 2023 | 7 | 2023 |
Heterogeneity in the costs of medical care among people living with HIV/AIDS in the United States B Enns, E Krebs, WC Mathews, RD Moore, KA Gebo, B Nosyk, ... Aids 33 (9), 1491-1500, 2019 | 7 | 2019 |
Prioritizing additional data collection to reduce decision uncertainty in the HIV/AIDS response in 6 US cities: a value of information analysis X Zang, H Jalal, E Krebs, A Pandya, H Zhou, B Enns, B Nosyk Value in Health 23 (12), 1534-1542, 2020 | 6 | 2020 |
Ending the HIV epidemic among persons who inject drugs: a cost-effectiveness analysis in six US cities E Krebs, X Zang, B Enns, JE Min, CN Behrends, C Del Rio, ... The Journal of infectious diseases 222 (Supplement_5), S301-S311, 2020 | 6 | 2020 |
Dissemination science to advance the use of simulation modeling: our obligation moving forward B Nosyk, J Weiner, E Krebs, X Zang, B Enns, CN Behrends, DJ Feaster, ... Medical Decision Making 40 (6), 718-721, 2020 | 6 | 2020 |
Geographic variation in the costs of medical care for people living with HIV in British Columbia, Canada B Enns, JE Min, D Panagiotoglou, JSG Montaner, B Nosyk, ... BMC health services research 19, 1-11, 2019 | 6 | 2019 |
A cost benefit analysis of a virtual overdose monitoring service/mobile overdose response service: the national overdose response service W Rioux, B Enns, J Jackson, H Quereshi, M Irvine, SM Ghosh Substance Abuse Treatment, Prevention, and Policy 18 (1), 57, 2023 | 4 | 2023 |
Cost-effectiveness of flexible take-home buprenorphine-naloxone versus methadone for treatment of prescription-type opioid use disorder B Enns, E Krebs, DGT Whitehurst, D Jutras-Aswad, B Le Foll, ME Socias, ... Drug and Alcohol Dependence 247, 109893, 2023 | 4 | 2023 |
The testing imperative: why the US ending the human immunodeficiency virus (HIV) epidemic program needs to renew efforts to expand HIV testing in clinical and community-based … B Nosyk, AT Fojo, P Kasaie, B Enns, L Trigg, M Piske, AB Hutchinson, ... Clinical Infectious Diseases 76 (12), 2206-2208, 2023 | 2 | 2023 |
Opioid analgesic prescribing for opioid‐naïve individuals prior to identification of opioid use disorder in British Columbia, Canada B Enns, E Krebs, T Thomson, LM Dale, JE Min, B Nosyk Addiction 116 (12), 3422-3432, 2021 | 2 | 2021 |
Estimating the potential value of MSM‐focused evidence‐based implementation interventions in three Ending the HIV Epidemic jurisdictions in the United States: a model‐based … B Enns, Y Sui, BC Guerra‐Alejos, L Humphrey, M Piske, X Zang, ... Journal of the International AIDS Society 27, e26265, 2024 | 1 | 2024 |
Comparative Analysis of Instrumental Variables on the Assignment of Buprenorphine/Naloxone or Methadone for the Treatment of Opioid Use Disorder F Homayra, B Enns, JE Min, M Kurz, P Bach, J Bruneau, S Greenland, ... Epidemiology 35 (2), 218-231, 2024 | 1 | 2024 |